Fate Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO

Bahram Valamehr

CEOBahram Valamehr

Employees

181

Employees181

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

181

Employees181

FATE Key Statistics

Market cap

153.61M

Market cap153.61M

Price-Earnings ratio

-0.87

Price-Earnings ratio-0.87

Dividend yield

—

Dividend yield—

Average volume

1.56M

Average volume1.56M

High today

$1.41

High today$1.41

Low today

$1.24

Low today$1.24

Open price

$1.30

Open price$1.30

Volume

1.20M

Volume1.20M

52 Week high

$5.92

52 Week high$5.92

52 Week low

$0.6611

52 Week low$0.6611

Analyst ratings

64%

of 11 ratings

Buy

36.4%

Hold

63.6%

Sell

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.